TuHURA Biosciences (HURA) Interest & Investment Income (2013 - 2026)
TuHURA Biosciences' (HURA) quarterly Interest & Investment Income came in at $21275.0 in Q1 2026, down 78.75% year-on-year from $100098.0 in Q1 2025, and up 3393.43% quarter-over-quarter from $609.0 in Q4 2025.
TuHURA Biosciences (HURA) Interest & Investment Income (2013 - 2026) Analysis & Trends
TuHURA Biosciences' Interest & Investment Income history runs 10 years deep, the most recent figure standing at $21275.0 for Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 78.75% year-over-year to $21275.0 in Q1 2026; TTM through Mar 2026 was $57410.0, a 84.44% decrease from a year earlier, with the FY2025 full-year figure at $136233.0, down 62.33% from the prior year.
- Interest & Investment Income improved to $21275.0 in Q1 2026 per HURA's latest filing, from $609.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $197449.0 in Q3 2024 and bottomed at $609.0 in Q4 2025.
- The 3-year median for Interest & Investment Income is $25370.5 (2025), against an average of $53285.1.
- Biggest YoY gain for Interest & Investment Income was 1407.05% in 2025; the steepest drop was 96.93% in 2025.
- Year by year, Interest & Investment Income stood at $197449.0 in 2024, then sank by 99.69% to $609.0 in 2025, then jumped by 3393.43% to $21275.0 in 2026.
- Per Business Quant, the three latest HURA Interest & Investment Income figures stand at $21275.0 (Q1 2026), $609.0 (Q4 2025), and $6060.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | TuHURA Biosciences | 132.62 Mn | 132.62 Mn | - | 21,275.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21,275.00 |
| Dec 31, 2025 | 609.00 |
| Sep 30, 2025 | 6,060.00 |
| Jun 30, 2025 | 29,466.00 |
| Mar 31, 2025 | 100,098.00 |
| Sep 30, 2024 | 197,449.00 |
| Jun 30, 2024 | 64,682.00 |
| Mar 31, 2024 | 6,642.00 |
| Mar 31, 2019 | 13,397.00 |
| Dec 31, 2018 | 16,272.00 |
| Sep 30, 2018 | 19,844.00 |
| Mar 31, 2018 | 5,850.00 |
| Dec 31, 2017 | 235.00 |
| Sep 30, 2017 | 156.00 |
| Mar 31, 2017 | 148.00 |
| Dec 31, 2016 | 60.00 |
| Sep 30, 2016 | 41.00 |
| Jun 30, 2016 | 179.00 |
| Mar 31, 2016 | -41.00 |
| Dec 31, 2015 | 10.00 |